Status:
COMPLETED
Pharmacokinetics and Pharmacodynamics Study of Oral Salmon Calcitonin in Healthy Postmenopausal Women
Lead Sponsor:
Novartis
Conditions:
Postmenopausal Osteoporosis
Eligibility:
FEMALE
40-70 years
Phase:
PHASE1
Brief Summary
This is a phase I study to analyze bioavailability and pharmacodynamic of two different variants of oral salmon calcitonin (SMC021) in postmenopausal women
Eligibility Criteria
Inclusion
- Healthy postmenopausal women
Exclusion
- Previous treatment with other osteoporosis medication
- Other protocol-defined inclusion/exclusion criteria may apply.
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
End Date :
November 1 2006
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT00411125
Start Date
August 1 2006
End Date
November 1 2006
Last Update
December 13 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Copenhagen, Denmark